Author:
Masnatta L. D.,Rubio M. C.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference20 articles.
1. Castelan Montalvo F.A., Martinez Hernandez G., Palmeros L. (1989): Comparative study of Clenbuterol and Salbutamol in the clinical control of the intercritical period in patients with recurrent bronchial asthma. Rev. Alerg. Mex., 36 (1), 28–30.
2. Baronti A., Grieco A., Vibelli C. (1980): Oral Nab 365 (Clenbuterol) in the chronic obstructive lung disease. A two double blind study. Int. J. Clin. Pharmacol. Biopharm., 18 (1), 21–25.
3. Tschan M., Perruchoud A., Herzog H. (1979): Dose response relationship of Clenbuterol (Nab 365) as a solution for inhalation. Eur. J. Clin. Pharmacol., 15, 159–162.
4. Lautt W.W., Legare D.J., Daniels T.R. (1984): The comparative effect of administration of substances via the hepatic artery or portal vein on hepatic arterial resistance, liver blood volume and hepatic extraction in cats. Hepatology, 4 (5), 927–932.
5. Greenway C.V., Lautt W.W. (1972): Effects of catecholamines, angiotensin, vasopressin and histamine on hepatic blood volume in the anesthetized cat. Br. J. Pharmacol., 44, 177–184.